Press Space to continue
Finding signal on Twitter is more difficult than it used to be. We curate the best tweets on topics like AI, startups, and product development every weekday so you can focus on what matters.
Press Space to continue
Press Space to continue
you aren't bullish enough on agentic biology. agentic biology is how we will cure cancer, rapidly build vaccines against superviruses, and enhance the human body beyond its natural limits and the reason is simple: time compression the FDA’s standard timeline puts discovery + preclinical work at 3-6 years before a drug even reaches human trials because the current process is agonizingly slow: → specialists spend months designing molecules for one disease target → a contract lab takes…
We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with @Anthropic: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like @chaidiscovery and @boltz_bio to pharmas like @Roche and @novonordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.